COVID-19 and anticoagulant based therapeutics: Approach with great promise

• Varun Kumar Sharma,
• Lomas Kumar Tomar,
• Charu Tyagi,
• Jayanad Manjhi,
• Yugandhar P. Reddy,
• Santosh Kumar Tiwari

Affiliations

Varun Kumar Sharma

Department of Biotechnology & Microbiology, School of Sciences, Noida International University-NIU, Gautam Budh Nagar, 201308 Uttar Pradesh, India; Centre for Liver Research and Diagnostics, Deccan College of Medical Sciences, Kanchanbagh, Hyderabad 500 058, Telangana, India; Corresponding author at: Department of Biotechnology and Microbiology, School of Sciences, Noida International University-NIU, Sector-17 A, Yamuna Expressway, Gautam Budh Nagar, 201308 Uttar Pradesh, India.

Lomas Kumar Tomar

Department of Biotechnology & Microbiology, School of Sciences, Noida International University-NIU, Gautam Budh Nagar, 201308 Uttar Pradesh, India; Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, Parktown 2193, South Africa

Charu Tyagi

Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, Parktown 2193, South Africa; School of Medicine, National University of Ireland Galway, University Road, Galway H91 TK33, Ireland

Jayanad Manjhi

Department of Biotechnology & Microbiology, School of Sciences, Noida International University-NIU, Gautam Budh Nagar, 201308 Uttar Pradesh, India

Yugandhar P. Reddy

Department of Zoology, The Adoni Arts and Science College, Adoni, Kurnool 518301, Andhra Pradesh, India

Santosh Kumar Tiwari

Centre for Liver Research and Diagnostics, Deccan College of Medical Sciences, Kanchanbagh, Hyderabad 500 058, Telangana, India; Clinical and Pathological laboratory, Invaluesys Research, Burgdorf 31303, Germany; Corresponding author at: Real-World Insights Group, Centre for Liver Research and Diagnostics, Deccan College of Medical Sciences, Kanchanbagh, Hyderabad 500 058, India.